The Partnership to Fight Infectious Disease (PFID) is a group of patients, providers, community organizations, academic researchers, business and labor groups, and infectious disease experts working to raise awareness of threats posed by infectious disease. As an initiative of the Partnership to Fight Chronic Disease, PFID will explore and advance solutions to address the need to enhance pandemic preparedness, address the growing threat of antimicrobial resistance and the need for new antimicrobial treatments; and empower informed choice and confidence in COVID-19 vaccines.
The COVID-19 crisis has reinforced the critical importance of treatments for infectious diseases. Ultimately, the development, availability, and adoption of safe and effective vaccines for COVID-19 are the quickest, safest way to control COVID-19 and enable normal activities to resume. We also need new antibiotics and anti-fungal medicines to treat the serious bacterial infections that can cause pneumonia or other complications related to COVID-19 illness. Our supply of effective antibiotics, however, is shrinking due to the growth of antimicrobial resistance (AMR).
- To anticipate and prepare for future pandemics, the United States needs to develop an effective National Pandemic Preparedness Strategy (NPPS) focused not only on the infectious pathogen, but also resulting, collateral health care challenges we can anticipate. National health emergencies threaten everyone, but pose a particularly acute danger to those with chronic and underlying conditions and those facing barriers to accessing care and other health disparities. You can review PFID's full statement of principles on pandemic prepardedness HERE.
- A press release on the launch of PFID can be found HERE. PFID's virtual launch event on June 26, 2020 can be viewed here: PFID Webinar VIDEO.
- PFCD/PFID Letter in Response to Senator Lamar Alexander's "Preparing for the Next Pandemic" White Paper
For more information on PFID - www.fightinfectiousdisease.org.